Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review

May 2021 | 44 pages | ID: NEFB700FA73EN
GlobalData

Abstracts

Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novan Inc (Novan) is a clinical development-stage biotechnology company that focuses on leveraging nitric oxide’s immunomodulatory and anti-microbial mechanisms of action for the treatment of diseases with unmet needs. The company’s products find application in the treatment of dermatology disorders, gastroenterology and women’s health. Its pipeline products focus on treating acne vulgaris, external genital warts, onychomycosis, psoriasis, molluscum, tinea pedis, human papillomavirus (HPV) and atopic dermatitis. Novan uses its proprietary technology Nitricil to develop new chemical entities with sustained delivery of nitric oxide. It works in collaboration with academic institutions, private and public companies and other universities. Novan is headquartered in Morrisville, North Carolina, the US.

Novan Inc Key Recent Developments

Mar 02,2021: Novan bolsters commercialization expertise with election of Steven D. Skolsky to board of directors
Jan 19,2021: Novan announces new corporate headquarters
Oct 30,2020: Novan reports third quarter 2020 financial results and provides corporate update
Oct 14,2020: Novan’s Nitricil technology shows in vitro antiviral effect against sars-cov-2 in human airway infection model
Sep 24,2020: Novan strengthens financial leadership with appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Novan Inc - Key Facts
Novan Inc - Key Employees
Novan Inc - Key Employee Biographies
Novan Inc - Major Products and Services
Novan Inc - History
Novan Inc - Company Statement
Novan Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Novan Inc - Business Description
Business Segment: Government Research Contracts and Grants
Performance
Business Segment: License and collaboration
Performance
R&D Overview
Novan Inc - SWOT Analysis
SWOT Analysis - Overview
Novan Inc - Strengths
Novan Inc - Weaknesses
Novan Inc - Opportunities
Novan Inc - Threats
Novan Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Novan Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 02, 2021: Novan bolsters commercialization expertise with election of Steven D. Skolsky to board of directors
Jan 19, 2021: Novan announces new corporate headquarters
Oct 30, 2020: Novan reports third quarter 2020 financial results and provides corporate update
Oct 14, 2020: Novan’s Nitricil technology shows in vitro antiviral effect against sars-cov-2 in human airway infection model
Sep 24, 2020: Novan strengthens financial leadership with appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors
Jul 28, 2020: Novan President and CEO, Paula Brown Stafford named Chairman of the Board
Apr 22, 2020: NOVAN announces paycheck protection program term note
Apr 20, 2020: Novan announces comprehensive evaluation of strategic and financial alternatives

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Novan Inc, Key Facts
Novan Inc, Key Employees
Novan Inc, Key Employee Biographies
Novan Inc, Major Products and Services
Novan Inc, History
Novan Inc, Key Competitors
Novan Inc, Ratios based on current share price
Novan Inc, Annual Ratios
Novan Inc, Annual Ratios (Cont...1)
Novan Inc, Interim Ratios
Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Novan Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Novan Inc, Performance Chart (2016 - 2020)
Novan Inc, Ratio Charts
Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Novan Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021